PLSE — Pulse Biosciences Share News
0.000.00%
Last trade - 00:00- $1.97bn
- $1.90bn
- $0.35m
Pulse Biosciences Inc expected to post a loss of 52 cents a share - Earnings Preview
Pulse Biosciences Inc reports results for the quarter ended in December - Earnings Summary
Brief: Pulse Biosciences Says On March 31, 2022, Company Initiated A Plan To Reduce Its Operating Expenses, Preserve Financial Resources
Pulse Biosciences Inc expected to post a loss of 51 cents a share - Earnings Preview
Pulse Biosciences Inc expected to post a loss of 51 cents a share - Earnings Preview
Brief: Pulse Biosciences Provides Update On Recent FDA 510(k) Submission
Brief: Pulse Biosciences Announces Preliminary Fourth Quarter And Full Year 2021 Financial And Operational Results
Pulse Biosciences Inc reports results for the quarter ended in September - Earnings Summary
Brief: Pulse Biosciences Reports Third Quarter 2021 Financial Results
Pulse Biosciences Inc expected to post a loss of 53 cents a share - Earnings Preview
Brief: Pulse Biosciences Selling Securityholder May Offer Or Sell 3 Million Shares
Pulse Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Brief: Pulse Biosciences Posts Quarterly Loss Per Share Of $0.58
Pulse Biosciences Inc expected to post a loss of 69 cents a share - Earnings Preview
Brief: Pulse Biosciences Announces $50 Million Private Placement
Brief: Pulse Biosciences Inc - Announces Health Canada Approval For Cellfx System
Pulse Biosciences Inc reports results for the quarter ended in March - Earnings Summary
Brief: Pulse Biosciences Posts Q1 Loss Per Share Of 71 Cents
Pulse Biosciences Inc expected to post a loss of 49 cents a share - Earnings Preview